NCT02167711View on ClinicalTrials.gov

Treatment for Bile Duct Cancer in the Liver

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 17, 2014

Primary Completion Date

January 31, 2023

Study Completion Date

February 8, 2023

Conditions
Cholangio Carcinoma
Interventions
DRUG

SIRT Yttrium-90

Trial Locations (1)

Unknown

Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT02167711 - Treatment for Bile Duct Cancer in the Liver | Biotech Hunter | Biotech Hunter